Fluorescence polarization immunoassay and HPLC assays compared for measuring monoethylglycinexylidide in liver-transplant patients.
We compared fluorescence polarization immunoassay (FPIA, x) and HPLC (y) for measuring monoethylglycinexylidide (MEGX) concentrations in 119 serum samples from 61 liver-transplant donors and recipients. The correlation between the two methods was y = 1.48 micrograms/L + 0.8x (r = 0.89). The bias (mean difference) was 12 micrograms/L (0.055 mumol/L) through the MEGX concentration range measured (0-250 micrograms/L, 0-1.136 mumol/L). We observed a major difference between the two methods in samples from four recipients and one donor. Cross-reactivity in FPIA with lignocaine and two of its metabolites (glycinexylidide and 2,6-xylidine) was < 3%. Samples with high bilirubin concentrations (> 200 mumol/L) required dilution before assay of MEGX by FPIA. Although there was an increase in apparent MEGX concentrations in some samples with increased bilirubin concentrations, the relationship was not constant. Increased plasma concentrations of cholesterol and triglyceride resulted in relatively small increases in apparent MEGX concentrations.
Chen
Y
Y
Department of Clinical Pharmacology, Princess Alexandra Hospital, Woolloongabba, Australia.
Potter
J M
JM
D001663:Bilirubin / Q000097:blood; D002784:Cholesterol / Q000097:blood; D002851:Chromatography, High Pressure Liquid / Q000706:statistics & numerical data; D005454:Fluorescence Polarization / Q000706:statistics & numerical data; D006801:Humans; D008012:Lidocaine / Q000031:analogs & derivatives* / Q000097:blood; D016031:Liver Transplantation; D011786:Quality Control; D012016:Reference Values; D014280:Triglycerides / Q000097:blood
D014280:Triglycerides; D002784:Cholesterol; D008012:Lidocaine; C001306:glycinexylidide; C001173:monoethylglycinexylidide; D001663:Bilirubin